Ergebnis der Suchanfrage nach celle

BASF SE

BASF Extends US$37 Cash Tender Offer to April 28, 2006

Ludwigshafen, Germany (ots/PRNewswire) - BASF Aktiengesellschaft (Frankfurt: BAS; NYSE: BF [ADR]; LSE: BFA; SWX: AN) today announced that, through its wholly owned subsidiary, Iron Acquisition Corporation, it has extended the expiration date of its US$37 cash tender offer for all of the issued and outstanding shares of common stock of Engelhard Corporation (NYSE: EC) to 5:00 p.m., New York City time, on Friday, ...

BWT AG

euro adhoc: BWT Aktiengesellschaft / Financial Figures/Balance Sheet / BWT presents the annual financial statements for 2005

Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 05.04.2006 Reporting net income of EUR19.0 million, BWT, Europe´s leading residential water treatment technology group, completes a historic year 2005. Effective November 8, 2005, the division ...

BWT AG

euro adhoc: BWT Aktiengesellschaft / Financial Figures/Balance Sheet / BWT 2005: Strategic refocusing started with growth of EBIT (+9.8%) and net income (+12.6%)

Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 08.03.2006 CHRIST WATER TECHNOLOGY AG and its subsidiaries were deconsolidated on October 31, 2005 in accordance with international accounting regulations. This means that the "AST - Aqua ...

BASF SE

BASF Commences US$37 Per Share Cash Tender Offer for Engelhard

Ludwigshafen, Germany (ots) - BASF Aktiengesellschaft (Frankfurt: BAS, NYSE: BF [ADR], LSE: BFA, SWX: AN), the world's leading chemical company, today announced that it is commencing a cash tender offer for all of the outstanding shares of common stock of Engelhard Corporation (NYSE: EC) for US$37.00 net per share. BASF's price represents a 23% premium above the December 20, 2005 closing price of Engelhard's ...

BASF SE

BASF Makes All-Cash Proposal To Acquire Engelhard

Ludwigshafen, Germany (ots) - * BASF Intends To Offer US$37.00 Per Share For a Total of US$4.9 Billion * Acquisition Would Make BASF a Leading Provider in the Global Catalyst Business BASF Aktiengesellschaft (Frankfurt: BAS, NYSE: BF [ADR], LSE: BFA, SWX: AN), the world's leading chemical company, has made an all-cash proposal to acquire all outstanding shares of common stock of Engelhard ...

BWT AG

euro adhoc: BWT Aktiengesellschaft / quarterly or semiannual financial statement / BWT posts sales and earnings increase after three quarters

Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 30.11.2005 Sales: EUR 361.9 million, +1.8% y.o.y. Consolidated BWT Group sales rose in the first nine months of 2005 as against the previous year from EUR 355.3 million to EUR 361.9 million ...

Andritz AG

euro adhoc: Andritz AG / other / Andritz to supply complete Greenfield Fiber System to Vietnam

Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 25.11.2005 Graz, 25 November 2005. International Technology Group Andritz AG, Austria received an order from Tracodi, Vietnam for construction of a greenfield mill for producing market pulp from the annual crop kenaf. The order value for Andritz ...

Boehringer Ingelheim

New Data Demonstrate Efficacy of Two Leading Anti-HIV Treatments

Dublin, Ireland, November 21 (ots/PRNewswire) - - New hope for HIV/AIDS patients: APTIVUS(R) outperforms several commonly prescribed drugs in the protease inhibitor (PI) class DUBLIN, Ireland, November 21 /PRNewswire/ -- - Experts Emphasize Need for Effective Therapy in Response to Increased Prevalence of HIV/AIDS throughout Europe At the 10th European AIDS Clinical Society (EACS) conference, experts ...

Boehringer Ingelheim

APTIVUS(R) Sustains Convincing Anti-HIV Effect Through 48 Weeks

Dublin, Ireland, November 21 (ots/PRNewswire) - - Additional Data Provide Further Guidance on Maximizing Treatment Response with APTIVUS(R) New data presented at the 10th European AIDS Conference (EACS) in Dublin demonstrate that through 48 weeks, APTIVUS(R) (tipranavir) provides a convincing and durable benefit, achieving and maintaining a superior treatment response in patients with resistant HIV.(1) ...

feratel media technologies AG

euro adhoc: feratel media technologies AG / Financial Figures/Balance Sheet / Q1 sales and results unchanged

Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 30.09.2005 "The 2005/2006 financial year got off to a positive start for feratel. Consolidated sales increased from TEUR 2,753.7 in the first quarter of the previous year to TEUR 2,812.1 in the ...

BWT AG

euro adhoc: BWT Aktiengesellschaft / Quarterly or Semiannual Financial Statements / BWT generates significant earnings growth in first half-year "CHRIST" industrial segment posts earnings

Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 04.08.2005 BWT - the Best Water Technology Group - can report a satisfactory increase in earnings in the first half of the 2005 financial year. The Aqua Systems Technologies segment (AST) made a ...

Boehringer Ingelheim

Positive Opinion in Europe for Tipranavir

Rio De Janeiro, Brazil and Ingelheim, Germany (ots/PRNewswire) - - New Data Support its Use as Powerful Treatment Against HIV Drug Resistance RIO DE JANEIRO, Brazil and INGELHEIM, Germany, July 28 /PRNewswire/ -- Boehringer Ingelheim announced today that the CHMP (Committee for Medicinal Products for Human Use) in London has issued a positive opinion for tipranavir, a non-peptidic protease inhibitor, to ...

BWT AG

euro adhoc: BWT Aktiengesellschaft / Mergers - Acquisitions - Takeovers / BWT AKTIENGESELLSCHAFT IS PLANNING TO SPIN OFF CHRIST WATER TECHNOLOGY AG WITH ITS BUSINESS DIVISION AQUA SYSTEMS TECHNOLOGIES

Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 27.06.2005 Mondsee, 28 June 2005: BWT Aktiengesellschaft, Europe's market leader in the water treatment sector, is planning to spin off its wholly owned subsidiary Christ Water Technology AG ...

Boehringer Ingelheim

U.S. FDA Approves New Anti-HIV Drug Aptivus(R) for Use in Combination Therapy

Ridgefield, Connecticut (ots/PRNewswire) - - The Following Press Release Was Issued By Our U.S. Affiliate Boehringer Ingelheim Pharmaceuticals, Inc. in The United States on June 23, 2005 Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Aptivus(R) (tipranavir) ...

BWT AG

euro adhoc: BWT Aktiengesellschaft / Quarterly or Semiannual Financial Statements / BWT makes budget for first quarter of 2005

Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 11.05.2005 BWT - the Best Water Technology Group - has made a good start to the 2005 financial year, achieving a 15 % increase in earnings and continued high levels of sales. Consolidated ...

Boehringer Ingelheim

Efficacy of Investigational Anti-HIV Agent Tipranavir Demonstrated by New Data

INGELHEIM, Germany,, February 28 (ots/PRNewswire) - - Tipranavir/r More Effective Than Lopinavir/r in Large-Scale Studies of Treatment-Experienced HIV-Positive Patients New data from multiple analyses presented last week at the 12th Conference on Retroviruses and Opportunistic Infections support the efficacy of the investigational non-peptidic protease ...

Boehringer Ingelheim

Boehringer Ingelheim Announces 24-Week Results From Second Phase III Pivotal Study of Tipranavir

Glasgow, Scotland, November 18 (ots/PRNewswire) - - RESIST-2 Data Demonstrate Efficacy in Treatment-Experienced Patient Population New tipranavir pivotal Phase III data show that a statistically significant higher percentage of treatment-experienced HIV-positive patients taking tipranavir therapy achieved treatment response versus those taking other ...

Boehringer Ingelheim

Boehringer Ingelheim Announces 24-Week Interim Results from Tipranavir RESIST-1 Phase 3 Study

Washington, November 1 (ots/PRNewswire) - New data from a pivotal Phase 3 study (RESIST-1) demonstrate that a statistically significant greater percentage of HIV-positive patients taking a tipranavir-based regimen achieved a treatment response versus those taking a regimen containing one of several marketed protease inhibitors (PIs). Treatment response in this study ...

Mazda

World Premiere of the New Mazda3 at the International Motor Show in Frankfurt

Medigene AG

euro adhoc: MediGene AG / MediGene discontinues development of CVLP tumor vaccine (E)

Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Martinsried/San Diego, March 25, 2003. The biopharmaceutical company MediGene AG (TechDax30: MDG) will discontinue the development project of a CVLP tumor vaccine against cervical cancer. The data obtained from a clinical phase 1/2 trial with the ...

ScheBo Biotech AG

The Forgotten Organ - Why to Screen for Exocrine Pancreatic Malfunction with respect to Diabetes Mellitus! / Tumour Metabolism - A Novel Concept Closes a Clinical Gap!

Giessen, Germany (ots) - Diabetes mellitus and cancer are among the diseases of greatest clinical focus. At the ScheBo Biotech AG Symposium during MEDICA on the occasion of the World Congress of Pathology and Laboratory Medicine (WASPaLM) 2001 two specific diagnostic tools with unique clinical approaches will be ...

Bertelsmann SE & Co. KGaA

Hartmut Ostrowski appointed to Bertelsmann AG Executive Board as successor to Gunter Thielen / Head of successful Bertelsmann Services Group to head up Arvato as of September 2002 - growth and excellent customer service as top priorities

Gütersloh (ots) - The Bertelsmann AG Supervisory Board has appointed Hartmut Ostrowski, 43, as a deputy member of the Bertelsmann Executive Board, effective October 1, 2001. Ostrowski is scheduled to become a regular Executive Board member on September 1, 2002. He will then become the successor to Gunter ...

ADVA Optical Networking SE

ots Ad hoc-Service: ADVA AG <DE0005103006> ADVA OPTICAL NETWORKING REPORTS 2000 FINANCIAL RESULTS

Ad hoc-announcement. The sender is solely responsible for the contents of this announcement. Internet: ...

BWT AG

ots Ad hoc-Service: BWT AG <AT0000737705>BWT BUSINESS DEVELOPMENT IN 2000 RECORD RESULT FORMS THE BASIS FOR DYNAMIC INTERNATIONALISATION

Ad hoc-announcement. The sender is solely responsible for the contents of this announcement. Internet: ...